News About: Goverment
Assembly panel to approve bill on substandard drugs recall
A National Assembly panel will pass a bill under which drug manufacturers (importers or distributors) would be obliged to voluntarily recall substandard drugs from March 2007, when they are found to be defective.
U...
413 NHI drug prices slashed as of Sept. 1.
The MOHW announced the total 412 NHI drug prices including 404 drugs of which their actual transacted lower prices were detected, taking effect from coming Sept. 1.
On other hand the NHI price list included 86 new ...
US raised 16-point proposals in Singapore meeting
The government disclosed 16-point proposals related to Korea's new drug pricing policy, which were demanded by the United States in the Singapore meeting, and the salient points of which are as follows:
1) Easier a...
Total 10,380 billion won of NHI payment in 1/2 of 2006.
The NHI revenue and disbursement rose in a double digit number, showing the total 10,380 billion won during the first half of this year compared to 9,610 billion won in the same period last year, the growth of which w...
Public health insurance covers 3.9 trillion won of pharmacy dispensing charge in first half
The dispensing charges claimed by 20,055 pharmacies in the first half of this year reached 3.9 trillion won, up 8.2 percent compared with the same period last year, according to statistics released by the Health...
Court ruling rekindles controversy over handling of oriental medicines
Controversy over oriental medicines has been rekindled as a court ruled that the simple acts of selling oriental drugs did not violate the current Pharmaceutical Affairs Law.
The ruling by the high court in Pusan c...
FTA talks on pharmaceuticals disclosed
Yakup Shinmoon said it has exclusively made public the contents of ongoing free trade agreement (FTA) talks with the United States on pharmaceuticals and medical equipment.
The contents of the FTA showed the negot...
Review terms for new drug applications to shorten at 5 years.Currently the KFDA's review time for any new drug applications takes about 6 years but the MOHW is now actively considering it to shorten at 5 years.
The MOHW also positively...
|
Appointment of bio equivalency test institutes in trouble.
Recently the court accepted the re-test appeal claimed in the administrative lawsuit raised by 35 pharmaceutical industry against the bio test fraud scandal, but up to now the KFDA has not appointed the test institute...
KFDA to be restructured on Aug. 25.
As of Aug. 25, a draft of the revised working rules on the responsibilities of the KFDA and its affiliates was fixed and promulgated, by which 9 teams will be newly established, 128 personnels will be increased and th...
